Sensitivity of mice to lipopolysaccharide is increased by a high saturated fat and cholesterol diet View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2007-11-12

AUTHORS

Hong Huang, Tongzheng Liu, Jane L Rose, Rachel L Stevens, Dale G Hoyt

ABSTRACT

BackgroundIt was hypothesized that a pro-atherogenic, high saturated fat and cholesterol diet (HCD) would increase the inflammatory response to E. coli endotoxin (LPS) and increase its concentration in plasma after administration to mice.MethodsC57Bl/6 mice were fed a HCD or a control diet (CD) for 4 weeks, and then treated with saline, 0.5, 1 or 2 mg LPS/kg, ip. Liver injury (alanine:2-oxoglutarate aminotransferase and aspartate aminotransferase, collagen staining), circulating cytokines (tumor necrosis factor-α, interleukin-6 and interferon-γ), factors that can bind LPS (serum amyloid A, apolipoprotein A1, LPS binding protein, and CD14), and plasma levels of LPS were measured. The hepatic response was assessed by measuring vascular cell adhesion molecule (VCAM)-1, inducible nitric oxide synthase (iNOS) and signal transducer and activator of transcription-1 proteins, and VCAM-1 and iNOS mRNAs. Hepatic mRNA encoding the LPS receptor, Toll like receptor 4, was also determined.ResultsTwo mg LPS/kg killed 100% of mice fed HCD within 5 d, while no mice fed CD died. All mice treated with 0 to 1 mg LPS/kg survived 24 h. HCD increased plasma alanine:2-oxoglutarate aminotransferase and aspartate aminotransferase, and the enzymes were increased more by LPS in HCD than CD mice. Induction of plasma tumor necrosis factor-α, interleukin-6, and interferon-γ by LPS was greater with HCD than CD. Hepatic VCAM-1 and iNOS protein and mRNA were induced by LPS more in mice fed HCD than CD. Tyrosine phosphorylation of signal transducer and activator of transcription-1 caused by LPS was prolonged in HCD compared with CD mice. Despite the hepatic effects of HCD, diet had no effect on the LPS plasma concentration-time profile. HCD alone did not affect circulating levels of plasma apolipoprotein A1 or LPS binding protein. However, plasma concentrations of serum amyloid A and CD14, and hepatic toll-like receptor-4 mRNA were increased in mice fed HCD.ConclusionHCD increased the sensitivity of mice to LPS without affecting its plasma level. Although increased serum amyloid A and CD14 in the circulation may inhibit LPS actions, their overexpression, along with hepatic toll-like receptor-4 or other factors, may contribute to the heightened sensitivity to LPS. More... »

PAGES

22

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1476-9255-4-22

DOI

http://dx.doi.org/10.1186/1476-9255-4-22

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1037556817

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/17997851


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1101", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Biochemistry and Metabolomics", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Center for Cardiovascular Medicine, Columbus Children's Research Institute, 43205, Columbus, OH, USA", 
          "id": "http://www.grid.ac/institutes/grid.240344.5", 
          "name": [
            "Division of Pharmacology, The Ohio State University College of Pharmacy, 43210, Columbus, OH, USA", 
            "Center for Cardiovascular Medicine, Columbus Children's Research Institute, 43205, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Huang", 
        "givenName": "Hong", 
        "id": "sg:person.0652424261.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652424261.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Pharmacology, The Ohio State University College of Pharmacy, 43210, Columbus, OH, USA", 
          "id": "http://www.grid.ac/institutes/grid.261331.4", 
          "name": [
            "Division of Pharmacology, The Ohio State University College of Pharmacy, 43210, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "Tongzheng", 
        "id": "sg:person.01362107006.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362107006.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Pharmacology, The Ohio State University College of Pharmacy, 43210, Columbus, OH, USA", 
          "id": "http://www.grid.ac/institutes/grid.261331.4", 
          "name": [
            "Division of Pharmacology, The Ohio State University College of Pharmacy, 43210, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rose", 
        "givenName": "Jane L", 
        "id": "sg:person.0717201424.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717201424.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Pharmacology, The Ohio State University College of Pharmacy, 43210, Columbus, OH, USA", 
          "id": "http://www.grid.ac/institutes/grid.261331.4", 
          "name": [
            "Division of Pharmacology, The Ohio State University College of Pharmacy, 43210, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stevens", 
        "givenName": "Rachel L", 
        "id": "sg:person.0756546055.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0756546055.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Dorothy M. Davis Heart and Lung Research Institute, 43210, Columbus, OH, USA", 
          "id": "http://www.grid.ac/institutes/grid.261331.4", 
          "name": [
            "Division of Pharmacology, The Ohio State University College of Pharmacy, 43210, Columbus, OH, USA", 
            "The Dorothy M. Davis Heart and Lung Research Institute, 43210, Columbus, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hoyt", 
        "givenName": "Dale G", 
        "id": "sg:person.01242743756.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242743756.91"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00134-006-0432-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031532576", 
          "https://doi.org/10.1007/s00134-006-0432-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1476-9255-2-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041956516", 
          "https://doi.org/10.1186/1476-9255-2-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00535-006-1883-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044225383", 
          "https://doi.org/10.1007/s00535-006-1883-1"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2007-11-12", 
    "datePublishedReg": "2007-11-12", 
    "description": "BackgroundIt was hypothesized that a pro-atherogenic, high saturated fat and cholesterol diet (HCD) would increase the inflammatory response to E. coli endotoxin (LPS) and increase its concentration in plasma after administration to mice.MethodsC57Bl/6 mice were fed a HCD or a control diet (CD) for 4 weeks, and then treated with saline, 0.5, 1 or 2 mg LPS/kg, ip. Liver injury (alanine:2-oxoglutarate aminotransferase and aspartate aminotransferase, collagen staining), circulating cytokines (tumor necrosis factor-\u03b1, interleukin-6 and interferon-\u03b3), factors that can bind LPS (serum amyloid A, apolipoprotein A1, LPS binding protein, and CD14), and plasma levels of LPS were measured. The hepatic response was assessed by measuring vascular cell adhesion molecule (VCAM)-1, inducible nitric oxide synthase (iNOS) and signal transducer and activator of transcription-1 proteins, and VCAM-1 and iNOS mRNAs. Hepatic mRNA encoding the LPS receptor, Toll like receptor 4, was also determined.ResultsTwo mg LPS/kg killed 100% of mice fed HCD within 5 d, while no mice fed CD died. All mice treated with 0 to 1 mg LPS/kg survived 24 h. HCD increased plasma alanine:2-oxoglutarate aminotransferase and aspartate aminotransferase, and the enzymes were increased more by LPS in HCD than CD mice. Induction of plasma tumor necrosis factor-\u03b1, interleukin-6, and interferon-\u03b3 by LPS was greater with HCD than CD. Hepatic VCAM-1 and iNOS protein and mRNA were induced by LPS more in mice fed HCD than CD. Tyrosine phosphorylation of signal transducer and activator of transcription-1 caused by LPS was prolonged in HCD compared with CD mice. Despite the hepatic effects of HCD, diet had no effect on the LPS plasma concentration-time profile. HCD alone did not affect circulating levels of plasma apolipoprotein A1 or LPS binding protein. However, plasma concentrations of serum amyloid A and CD14, and hepatic toll-like receptor-4 mRNA were increased in mice fed HCD.ConclusionHCD increased the sensitivity of mice to LPS without affecting its plasma level. Although increased serum amyloid A and CD14 in the circulation may inhibit LPS actions, their overexpression, along with hepatic toll-like receptor-4 or other factors, may contribute to the heightened sensitivity to LPS.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1476-9255-4-22", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1034480", 
        "issn": [
          "1078-7852", 
          "1476-9255"
        ], 
        "name": "Journal of Inflammation", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "4"
      }
    ], 
    "keywords": [
      "inducible nitric oxide synthase", 
      "serum amyloid A", 
      "sensitivity of mice", 
      "LPS/", 
      "control diet", 
      "CD mice", 
      "cholesterol diet", 
      "plasma levels", 
      "receptor 4", 
      "amyloid A", 
      "VCAM-1", 
      "Toll-like receptor 4 (TLR4) mRNA", 
      "hepatic toll-like receptor 4", 
      "plasma tumor necrosis factor", 
      "Toll-like receptor 4", 
      "vascular cell adhesion molecule", 
      "receptor 4 mRNA", 
      "nitric oxide synthase", 
      "tumor necrosis factor", 
      "plasma concentration-time profiles", 
      "E. coli endotoxin", 
      "plasma apolipoprotein A1", 
      "concentration-time profiles", 
      "MethodsC57BL/6 mice", 
      "liver injury", 
      "signal transducer", 
      "oxide synthase", 
      "interleukin-6", 
      "hepatic effects", 
      "inflammatory response", 
      "necrosis factor", 
      "plasma concentrations", 
      "iNOS mRNA", 
      "cell adhesion molecule", 
      "LPS action", 
      "coli endotoxin", 
      "apolipoprotein A1", 
      "iNOS protein", 
      "hepatic response", 
      "transcription 1 (STAT1) protein", 
      "aspartate aminotransferase", 
      "LPS receptor", 
      "LPS", 
      "mice", 
      "hepatic mRNA", 
      "adhesion molecules", 
      "diet", 
      "CD14", 
      "transcription 1", 
      "aminotransferase", 
      "mRNA", 
      "fat", 
      "tyrosine phosphorylation", 
      "HCD", 
      "cytokines", 
      "BackgroundIt", 
      "injury", 
      "activator", 
      "interferon", 
      "factors", 
      "levels", 
      "endotoxin", 
      "administration", 
      "ResultsTwo", 
      "protein", 
      "weeks", 
      "saline", 
      "response", 
      "receptors", 
      "sensitivity", 
      "plasma", 
      "induction", 
      "overexpression", 
      "effect", 
      "synthase", 
      "concentration", 
      "phosphorylation", 
      "oxoglutarate aminotransferase", 
      "circulation", 
      "toll", 
      "A1", 
      "action", 
      "enzyme", 
      "profile", 
      "transducer", 
      "IP", 
      "molecules"
    ], 
    "name": "Sensitivity of mice to lipopolysaccharide is increased by a high saturated fat and cholesterol diet", 
    "pagination": "22", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1037556817"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1476-9255-4-22"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "17997851"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1476-9255-4-22", 
      "https://app.dimensions.ai/details/publication/pub.1037556817"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T20:52", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_429.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1476-9255-4-22"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1476-9255-4-22'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1476-9255-4-22'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1476-9255-4-22'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1476-9255-4-22'


 

This table displays all metadata directly associated to this object as RDF triples.

194 TRIPLES      21 PREDICATES      115 URIs      104 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1476-9255-4-22 schema:about anzsrc-for:11
2 anzsrc-for:1101
3 schema:author Nd675cadbe0034f25903b1c83ce35916e
4 schema:citation sg:pub.10.1007/s00134-006-0432-y
5 sg:pub.10.1007/s00535-006-1883-1
6 sg:pub.10.1186/1476-9255-2-2
7 schema:datePublished 2007-11-12
8 schema:datePublishedReg 2007-11-12
9 schema:description BackgroundIt was hypothesized that a pro-atherogenic, high saturated fat and cholesterol diet (HCD) would increase the inflammatory response to E. coli endotoxin (LPS) and increase its concentration in plasma after administration to mice.MethodsC57Bl/6 mice were fed a HCD or a control diet (CD) for 4 weeks, and then treated with saline, 0.5, 1 or 2 mg LPS/kg, ip. Liver injury (alanine:2-oxoglutarate aminotransferase and aspartate aminotransferase, collagen staining), circulating cytokines (tumor necrosis factor-α, interleukin-6 and interferon-γ), factors that can bind LPS (serum amyloid A, apolipoprotein A1, LPS binding protein, and CD14), and plasma levels of LPS were measured. The hepatic response was assessed by measuring vascular cell adhesion molecule (VCAM)-1, inducible nitric oxide synthase (iNOS) and signal transducer and activator of transcription-1 proteins, and VCAM-1 and iNOS mRNAs. Hepatic mRNA encoding the LPS receptor, Toll like receptor 4, was also determined.ResultsTwo mg LPS/kg killed 100% of mice fed HCD within 5 d, while no mice fed CD died. All mice treated with 0 to 1 mg LPS/kg survived 24 h. HCD increased plasma alanine:2-oxoglutarate aminotransferase and aspartate aminotransferase, and the enzymes were increased more by LPS in HCD than CD mice. Induction of plasma tumor necrosis factor-α, interleukin-6, and interferon-γ by LPS was greater with HCD than CD. Hepatic VCAM-1 and iNOS protein and mRNA were induced by LPS more in mice fed HCD than CD. Tyrosine phosphorylation of signal transducer and activator of transcription-1 caused by LPS was prolonged in HCD compared with CD mice. Despite the hepatic effects of HCD, diet had no effect on the LPS plasma concentration-time profile. HCD alone did not affect circulating levels of plasma apolipoprotein A1 or LPS binding protein. However, plasma concentrations of serum amyloid A and CD14, and hepatic toll-like receptor-4 mRNA were increased in mice fed HCD.ConclusionHCD increased the sensitivity of mice to LPS without affecting its plasma level. Although increased serum amyloid A and CD14 in the circulation may inhibit LPS actions, their overexpression, along with hepatic toll-like receptor-4 or other factors, may contribute to the heightened sensitivity to LPS.
10 schema:genre article
11 schema:isAccessibleForFree true
12 schema:isPartOf N733525ca19f14fab9a4394f0b0b83b0e
13 Nf8a675c8ae484ee69fb16227a9a3d8a6
14 sg:journal.1034480
15 schema:keywords A1
16 BackgroundIt
17 CD mice
18 CD14
19 E. coli endotoxin
20 HCD
21 IP
22 LPS
23 LPS action
24 LPS receptor
25 LPS/
26 MethodsC57BL/6 mice
27 ResultsTwo
28 Toll-like receptor 4
29 Toll-like receptor 4 (TLR4) mRNA
30 VCAM-1
31 action
32 activator
33 adhesion molecules
34 administration
35 aminotransferase
36 amyloid A
37 apolipoprotein A1
38 aspartate aminotransferase
39 cell adhesion molecule
40 cholesterol diet
41 circulation
42 coli endotoxin
43 concentration
44 concentration-time profiles
45 control diet
46 cytokines
47 diet
48 effect
49 endotoxin
50 enzyme
51 factors
52 fat
53 hepatic effects
54 hepatic mRNA
55 hepatic response
56 hepatic toll-like receptor 4
57 iNOS mRNA
58 iNOS protein
59 inducible nitric oxide synthase
60 induction
61 inflammatory response
62 injury
63 interferon
64 interleukin-6
65 levels
66 liver injury
67 mRNA
68 mice
69 molecules
70 necrosis factor
71 nitric oxide synthase
72 overexpression
73 oxide synthase
74 oxoglutarate aminotransferase
75 phosphorylation
76 plasma
77 plasma apolipoprotein A1
78 plasma concentration-time profiles
79 plasma concentrations
80 plasma levels
81 plasma tumor necrosis factor
82 profile
83 protein
84 receptor 4
85 receptor 4 mRNA
86 receptors
87 response
88 saline
89 sensitivity
90 sensitivity of mice
91 serum amyloid A
92 signal transducer
93 synthase
94 toll
95 transcription 1
96 transcription 1 (STAT1) protein
97 transducer
98 tumor necrosis factor
99 tyrosine phosphorylation
100 vascular cell adhesion molecule
101 weeks
102 schema:name Sensitivity of mice to lipopolysaccharide is increased by a high saturated fat and cholesterol diet
103 schema:pagination 22
104 schema:productId N9070568fa8874c33ae2ae3898a43deb5
105 Nb02915470efc469c853e2e65c31f4909
106 Nce07eed27afa462bafa68163d48ab8c6
107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037556817
108 https://doi.org/10.1186/1476-9255-4-22
109 schema:sdDatePublished 2022-11-24T20:52
110 schema:sdLicense https://scigraph.springernature.com/explorer/license/
111 schema:sdPublisher Na5b19c1b8be84e41968962b4540f76cc
112 schema:url https://doi.org/10.1186/1476-9255-4-22
113 sgo:license sg:explorer/license/
114 sgo:sdDataset articles
115 rdf:type schema:ScholarlyArticle
116 N2f4d186f5e2349cf8d6eda12db875d02 rdf:first sg:person.01362107006.03
117 rdf:rest N61b950def7c14092943f204427fe0596
118 N61b950def7c14092943f204427fe0596 rdf:first sg:person.0717201424.05
119 rdf:rest Nf094c1bed6054e74b3c7b74e9b633767
120 N733525ca19f14fab9a4394f0b0b83b0e schema:issueNumber 1
121 rdf:type schema:PublicationIssue
122 N9070568fa8874c33ae2ae3898a43deb5 schema:name dimensions_id
123 schema:value pub.1037556817
124 rdf:type schema:PropertyValue
125 N9efbbe00f6364064b39c930e6f49b58d rdf:first sg:person.01242743756.91
126 rdf:rest rdf:nil
127 Na5b19c1b8be84e41968962b4540f76cc schema:name Springer Nature - SN SciGraph project
128 rdf:type schema:Organization
129 Nb02915470efc469c853e2e65c31f4909 schema:name pubmed_id
130 schema:value 17997851
131 rdf:type schema:PropertyValue
132 Nce07eed27afa462bafa68163d48ab8c6 schema:name doi
133 schema:value 10.1186/1476-9255-4-22
134 rdf:type schema:PropertyValue
135 Nd675cadbe0034f25903b1c83ce35916e rdf:first sg:person.0652424261.23
136 rdf:rest N2f4d186f5e2349cf8d6eda12db875d02
137 Nf094c1bed6054e74b3c7b74e9b633767 rdf:first sg:person.0756546055.08
138 rdf:rest N9efbbe00f6364064b39c930e6f49b58d
139 Nf8a675c8ae484ee69fb16227a9a3d8a6 schema:volumeNumber 4
140 rdf:type schema:PublicationVolume
141 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
142 schema:name Medical and Health Sciences
143 rdf:type schema:DefinedTerm
144 anzsrc-for:1101 schema:inDefinedTermSet anzsrc-for:
145 schema:name Medical Biochemistry and Metabolomics
146 rdf:type schema:DefinedTerm
147 sg:journal.1034480 schema:issn 1078-7852
148 1476-9255
149 schema:name Journal of Inflammation
150 schema:publisher Springer Nature
151 rdf:type schema:Periodical
152 sg:person.01242743756.91 schema:affiliation grid-institutes:grid.261331.4
153 schema:familyName Hoyt
154 schema:givenName Dale G
155 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242743756.91
156 rdf:type schema:Person
157 sg:person.01362107006.03 schema:affiliation grid-institutes:grid.261331.4
158 schema:familyName Liu
159 schema:givenName Tongzheng
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362107006.03
161 rdf:type schema:Person
162 sg:person.0652424261.23 schema:affiliation grid-institutes:grid.240344.5
163 schema:familyName Huang
164 schema:givenName Hong
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652424261.23
166 rdf:type schema:Person
167 sg:person.0717201424.05 schema:affiliation grid-institutes:grid.261331.4
168 schema:familyName Rose
169 schema:givenName Jane L
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717201424.05
171 rdf:type schema:Person
172 sg:person.0756546055.08 schema:affiliation grid-institutes:grid.261331.4
173 schema:familyName Stevens
174 schema:givenName Rachel L
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0756546055.08
176 rdf:type schema:Person
177 sg:pub.10.1007/s00134-006-0432-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1031532576
178 https://doi.org/10.1007/s00134-006-0432-y
179 rdf:type schema:CreativeWork
180 sg:pub.10.1007/s00535-006-1883-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044225383
181 https://doi.org/10.1007/s00535-006-1883-1
182 rdf:type schema:CreativeWork
183 sg:pub.10.1186/1476-9255-2-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041956516
184 https://doi.org/10.1186/1476-9255-2-2
185 rdf:type schema:CreativeWork
186 grid-institutes:grid.240344.5 schema:alternateName Center for Cardiovascular Medicine, Columbus Children's Research Institute, 43205, Columbus, OH, USA
187 schema:name Center for Cardiovascular Medicine, Columbus Children's Research Institute, 43205, Columbus, OH, USA
188 Division of Pharmacology, The Ohio State University College of Pharmacy, 43210, Columbus, OH, USA
189 rdf:type schema:Organization
190 grid-institutes:grid.261331.4 schema:alternateName Division of Pharmacology, The Ohio State University College of Pharmacy, 43210, Columbus, OH, USA
191 The Dorothy M. Davis Heart and Lung Research Institute, 43210, Columbus, OH, USA
192 schema:name Division of Pharmacology, The Ohio State University College of Pharmacy, 43210, Columbus, OH, USA
193 The Dorothy M. Davis Heart and Lung Research Institute, 43210, Columbus, OH, USA
194 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...